Lewy bodies are a hallmark of Parkinson's disease (PD) and other related neurological conditions. Understanding why and how ...

Neuroscientists have uncovered a mechanism that controls the reactivation of neural stem cells, which are crucial for repairing and regenerating brain cells. The research offers exciting potential for ...

Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases pose significant health challenges due to neuron ...

Scientists have recreated the growth of Lewy bodies in human neurons and followed their formation to gain important insight ...

Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...

An international team of neuroscientists, led by Duke-NUS Medical School, have uncovered a mechanism that controls the ...

Scientists used stem cells to recreate the growth of Lewy bodies in human neurons to gain insight into why and how they form.

Reprogrammed stem cells are being tested in at least 50 clinical trials around the globe, and the first approved therapy ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

An international team of neuroscientists showed for the first time that modifying a protein that controls cell growth can ...